Position in AKTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,789,000
New position
Shares Held
100,000
first reported quarter
Ownership
0.181%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Laurion Capital Management LP holds $287,143,589 across 18 Biotechnology names. AKTS ranks #13 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,262,651 | $93,764,463 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,232,040 | $60,465,963 | |
| 3 | IMUX |
Immunic, Inc.
|
3,882,162 | $43,091,998 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
7,822,638 | $33,559,117 | |
| 5 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
1,922,656 | $17,207,771 | |
| 6 | PYXS |
Pyxis Oncology, Inc.
|
4,997,333 | $7,296,106 | |
| 7 | VOR |
Vor Biopharma Inc.
|
318,670 | $5,685,072 | |
| 8 | PEPG |
PepGen Inc.
|
2,750,855 | $4,869,013 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,789,000 | 100,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||